baito logo
    navigation?.buttons?.createJob?.text
    Candoro ethics GmbH header
    Candoro ethics GmbH logo
    #medizinischescannabis #cannabinoidforschung #gmpstandards

    Candoro ethics GmbH

    from Friedrichsdorf

    Candoro ethics GmbH, a subsidiary of Dermapharm AG, researches, develops and produces cannabinoid-containing pharmaceuticals in Germany. As a GMP-certified expert for medical cannabis, it offers innovative solutions for seriously ill patients.

    Visit websiteArrowRight

    The Candoro ethics GmbH is a subsidiary of Dermapharm AG and focuses on the research, development and manufacture of cannabinoid-containing medicinal products in Germany. Founded in 2023 and based in Friedrichsdorf near Frankfurt am Main, Candoro ethics combines over 25 years of industry experience and comprehensive know-how from more than 80,000 patient years. This makes the company a trustworthy partner for high-quality medical cannabis products that are produced according to GMP standards (Good Manufacturing Practice)[3][5].

    The core competence of Candoro ethics lies in the handling of narcotics, in particular in the field of cannabinoids and narcotics re-import (BtM re-import). At the modern production facility in Friedrichsdorf, supported by the sister company axicorp GmbH, Candoro ethics produces both natural and synthetic Dronabinol with a purity of over 98 %. This enables the company to offer a broad spectrum of cannabis-based active ingredients for the treatment of serious diseases and at the same time sets high quality standards in the medicinal cannabis industry[3].

    Candoro ethics is part of the Dermapharm Group, an innovative and growing manufacturer of branded pharmaceuticals and health products with 18 companies and around 3,500 employees at over 20 locations. Dermapharm pursues an integrated business model that ranges from development to production and quality assurance to sales. The Group is a market leader in selected therapeutic areas, particularly in Germany, and is continuously expanding its product portfolio and market presence through research, targeted acquisitions and internationalization[1][2][5].

    The corporate mission of Candoro ethics and Dermapharm focuses on providing excellent pharmaceutical quality at economical prices while meeting the demands of a modern, dynamic healthcare system. Sustainable production and environmental awareness play an important role in ensuring continuity and long-term success. Through modern production processes, strict quality controls and a strong commitment to research and development, Candoro ethics is positioning itself as a reliable player in the field of medical cannabinoids[3][5].

    In summary, as part of the Dermapharm Group, Candoro ethics offers specialized medical cannabis products that meet the highest pharmaceutical quality standards. It combines many years of expertise with innovative product development and thus contributes to improving the care of seriously ill patients. The company strives to promote sustainable and responsible manufacturing processes and actively shape the future of medical cannabinoid therapy.

    Quellen:

    Edit
    Edit